Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 23, 2020
- Accepted October 29, 2020
- Published online January 7, 2021.
Article Versions
- Earlier version (December 29, 2020 - 08:13).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2021 by the American Society of Nephrology
Author Information
- Vicente E. Torres1,
- Arlene B. Chapman2,
- Olivier Devuyst3,4,
- Ron T. Gansevoort5,
- Ronald D. Perrone6,
- Jennifer Lee7,
- Molly E. Hoke8,
- Alvin Estilo9,
- Olga Sergeyeva10
- 1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota
- 2Section of Nephrology, The University of Chicago School of Medicine, Chicago, Illinois
- 3Institute of Physiology, University of Zurich, Zurich, Switzerland
- 4Division of Nephrology, Université Catholique de Louvain Medical School, Brussels, Belgium
- 5Division of Nephrology, University Medical Center Groningen, Groningen, The Netherlands
- 6Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts
- 7Biostatistics, Otsuka Pharmaceutical Development & Commercialization, Rockville, Maryland
- 8Global Medical Affairs, Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey
- 9Clinical Safety and Pharmacovigilance, Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey
- 10Global Clinical Development, Otsuka Pharmaceutical Development & Commercialization, Princeton, New Jersey
- Correspondence:
Dr. Vicente E. Torres, Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905. Email: torres.vicente{at}mayo.edu
Funding
Otsuka Pharmaceutical
Statistics from Altmetric.com
Article usage
In this issue
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
Jump to section
More in this TOC Section
Original Articles
Cited By...
- No citing articles found.